Literature DB >> 18224414

Dramatic remission of anemia after thymectomy in a patient of idiopathic myelofibrosis with thymoma.

Ying-Yih Shih1, Liang-Tsai Hsiao, Ching-Fen Yang, Yu-Chung Wu, Tzeon-Jye Chiou.   

Abstract

Anemia is one of the characteristics of idiopathic myelofibrosis (IMF), and malignant thymoma is usually associated with various hematologic disorders, including anemia, pancytopenia, and hypogammaglobulinemia. However, the relationship between IMF and malignant thymoma has not been published before. Here, we report a 48-year-old woman who was initially diagnosed of IMF with severe anemia and transfusion dependent. Five years later, malignant thymoma was found when she was examined for chronic cough. After performing extended thymectomy, her anemia dramatically recovered to normal and sustained for 2 years till last follow-up. Her splenomegaly and myelofibrosis were also improved. We hypothesized that her malignant thymoma induced the progression of IMF, especially in anemia.

Entities:  

Mesh:

Year:  2007        PMID: 18224414     DOI: 10.1007/s12185-007-0012-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.

Authors:  Y Abe; K Ohshima; M Shiratsuchi; K Honda; J Nishimura; H Nawata; K Muta
Journal:  Eur J Haematol       Date:  2001-03       Impact factor: 2.997

Review 2.  A case of thymoma-associated autoimmune haemolytic anaemia.

Authors:  R J Rennenberg; P Pauwels; L T Vlasveld
Journal:  Neth J Med       Date:  1997-03       Impact factor: 1.422

3.  Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET).

Authors:  Giovanni Barosi; Dominique Bordessoule; Jean Briere; Francisco Cervantes; Jean-Loup Demory; Brigitte Dupriez; Heinz Gisslinger; Martin Griesshammer; Hans Hasselbalch; Rajko Kusec; Marie-Caroline Le Bousse-Kerdiles; Nicola L Liberato; Monia Marchetti; John T Reilly; Jurgen Thiele
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

Review 4.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

5.  Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients.

Authors:  Francisco Cervantes; Alberto Alvarez-Larrán; Abel Domingo; Eduardo Arellano-Rodrigo; Emili Montserrat
Journal:  Br J Haematol       Date:  2005-06       Impact factor: 6.998

Review 6.  Diagnosis and treatment of pure red cell aplasia.

Authors:  S B Krantz
Journal:  Med Clin North Am       Date:  1976-09       Impact factor: 5.456

7.  Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone.

Authors:  I Sadek; E Zayed; O Hayne; L Fernandez
Journal:  Am J Hematol       Date:  2000-08       Impact factor: 10.047

8.  Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor.

Authors:  H Shichino; H Mugishima; M Takamura; T Shimada; T Suzuki; M Chin; K Harada; S Ryo; S Kojima
Journal:  Acta Paediatr Jpn       Date:  1996-12

Review 9.  Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.

Authors:  Isela Velazquez; Blanche P Alter
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

10.  Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.

Authors:  P Rameshwar; V T Chang; U F Thacker; P Gascón
Journal:  Am J Hematol       Date:  1998-10       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.